Related Experiment Video
Updated: Jul 19, 2026

A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients
Published on: October 25, 2024
[Clinical aspects and management of patients with tuberculous meningitis. Retrospective analysis from 1994 to 2005]
P Bémer1, D Boutoille, D Lepelletier
1Service de Bactériologie-Hygiène, CHU Hôtel-Dieu, 44093 Nantes Cedex 1.
Abstract:
Tuberculous meningitis remains a devastating disease with poor prognosis in terms of mortality or invalidating after-effects. Eighteen cases of tuberculous meningitis, occurred between 1994 and 2005, were re-examined retrospectively. Among the 18 patients, 13 were aged from 14 to 64 years, and 5 were older than 64. There was no gender dominance. Factors of risk were identified in 7 patients. British Medical Research Council staging was III in 9 patients, II in 2 patients and I in 7 patients. Protein and glucose levels in the cerebrospinal fluid sample were very variable ranging from 0.4 to 10.7 g/L and 0.4 to 3.7 mmol/L respectively. The cellular reaction was also very variable ranging from 0 to 250 elements, mostly lymphocytes. Antituberculous treatment was given to 15 patients, associated with corticosteroid therapy for 9 patients. Among the 18 patients, 11 died within 1 year, 4 were treated for a recurrence occurring up to 6 years after the diagnosis, 1 presented important neuropsychic after-effects and 2 patients survived without after-effects with a time ranging between 6 months and 1 year. The deceased patients were significantly older than the others. The risk of mortality was 4.5-fold greater among stage III patients than among stage I and II patients. The use of corticosteroids significantly reduced the risk of death.
Insights
Tuberculous meningitis is a severe disease with high mortality. Early treatment with antitubercular drugs and corticosteroids improves survival, especially in advanced stages.
Area of Science:
- Neurology
- Infectious Diseases
- Public Health
Context:
- Tuberculous meningitis (TBM) presents a significant global health challenge, particularly in resource-limited settings.
- High mortality and long-term neurological deficits underscore the need for effective management strategies.
Purpose:
- To retrospectively analyze the clinical characteristics, treatment outcomes, and prognostic factors of tuberculous meningitis patients.
- To evaluate the impact of antitubercular therapy and corticosteroid use on TBM patient survival and sequelae.
Summary:
- This study reviewed 18 TBM cases (1994-2005), noting variable patient demographics, risk factors, and cerebrospinal fluid profiles.
- Outcomes included high mortality (11/18), recurrences (4/18), and neurological sequelae (1/18). Advanced British Medical Research Council stage III was associated with a 4.5-fold increased mortality risk.
- Corticosteroid use significantly reduced the risk of death, highlighting its importance in TBM management.
Impact:
- Findings emphasize the critical role of prompt diagnosis and combined therapy in improving TBM prognosis.
- Identifies advanced disease stage and older age as key predictors of mortality.
- Supports the integration of corticosteroids into standard TBM treatment protocols to mitigate mortality and improve patient outcomes.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Bacterial Meningitis I: Introduction
Cryptococcal Meningitis
Tuberculosis
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
